Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 42, 2018 - Issue 4
108
Views
1
CrossRef citations to date
0
Altmetric
Original Article

A Unique Interaction of IVS-I-1 (G>A) (HBA2: c.95+1G>A) with Hb Adana (HBA2: c.179G>A) Presenting as Transfusion-Dependent α-Thalassemia

, , , , , , , , , , , & show all
Pages 247-251 | Received 25 Apr 2018, Accepted 10 Sep 2018, Published online: 09 Jan 2019

References

  • Fucharoen S, Winichagoon P. Haemoglobinopathies in Southeast Asia. Indian J Med Res. 2011;134:498–506.
  • Rahimah A, Sabrina N, Bahrin S. Distribution of α thalasaemia in 16 year old Malaysian students in Penang, Melaka and Sabah. Med J Malaysia. 2012;67(6):562–567.
  • Aliza MY, Nor Asiah M, Manaf AA. Prevalence and disease burden of common α thalassemia deletions in Malaysian blood donors: a multi ethnic population. Int J Sci Res Pub. 2012;2(4):89–93.
  • Hafiza A, Jaapar NA, Azma RZ, et al. A case series of α-thalassemia intermedia due to compound heterozygosity for Hb Adana [HBA2: c.179G>A (or HBA1); p.Gly60Asp] with other α-thalassemias in Malay families. Hemoglobin. 2014;38(4):277–281.
  • Azma RZ, Ainoon O, Hafiza A, et al. Molecular characterization of α thalassaemia among patients diagnosed in UKM Medical Centre. Malaysia J Pathol. 2014;36(1):27–32.
  • Nainggolan IM, Harahap A, Setianingsih I. Hydrops fetalis associated with homozygosity for Hb Adana [α59(E8)Gly→Asp (α2)]. Hemoglobin. 2010;34(4):394–401.
  • Sollaino MC, Paglietti ME, Loi D, et al. Homozygous deletion of the major α-globin regulatory element (MCS-R2) responsible for a severe case of Hemoglobin H disease. Blood. 2010;116(12):2193–2194.
  • Clürük MA, Baysal E, Gupta RB, et al. An IVS-I-117 (G>A) acceptor splice site mutation in the HBA1 geneis a nondeletional α-thalassaemia-2 determinant in an Indian population. Br J Haematol. 1993;85(1):148–152.
  • Harteveld CL, Heister JG, Giordano PC, et al. An IVS1-116 (A>G) acceptor splice site mutation in the α2-globin gene causing α+-thalassaemia in two Dutch families. Br J Haematol. 1996;95(3):461–466.
  • Orkin SH, Goff SC, Hechtman RL. Mutation in an intervening sequence splice junction in man. Proc Natl Acad Sci USA. 1981;78(8):5041–5045.
  • Harteveld CL, Beijer C, van Delft P, et al. α-Thalassaemia as a result of a novel splice donor site mutation of the α-globin gene. Br J Haematol. 2000;110(3):694–698.
  • Çürük MA, Dimovski AJ, Baysal E, et al. Hb Adana or α 259(E8)Gly→Asp β2, a severely unstable α1-globin variant, observed in combination with the -(αa)20.5 Kb αa-thal-1 deletion in two Turkish patients. Am J Hematol. 1993;44(4):270–275.
  • George E, Tan JAMA, Nor Azian AS, et al. A rare case of α-thalassaemia intermedia in a Malay patient double heterozygous for α+-thalassaemia and a mutation in α;1 globin gene CD59 (GGC>GAC)). Med J Malaysia. 2009;64(4):321–322.
  • Rahimah A, Mohamed S, Nisha S, et al. Distribution of α-thalassaemia gene variants in diverse ethnic populations in malaysia: data from the institute for medical research. Int J Mol Sci. 2013;14(9):18599–18614.
  • Viprakasit V, Ekwattanakit S, Chalaow N, et al. Clinical presentation and molecular identification of four uncommon α globin variants in Thailand. Acta Haematol. 2014;131(2):88–94.
  • Waye JS, Eng B, Dutly F, et al. α-Thalassemia caused by two novel splice mutations of the α2-globin gene: IVS-I-1 (G>A and G>T)). Hemoglobin. 2009;33(6):519–522.
  • Qadah T, Finlayson J, Ghassemifar R. In vitro characterization of the α-thalassemia point mutation HBA2:c.95+1G>A [IVS-I-1(G>A) (α2)]. Hemoglobin. 2012;36(1):38–46.
  • Traeger-Synodinos J, Metaxotou-Mavrommati A, Karagiorga M, et al. Interaction of an α+-thalassemia deletion with either a highly unstable α-globin variant (α2, codon 59, GGC→GAC) or a nondeletional α-thalassemia mutation (AATAAA→ AATAAG): comparison of phenotypes illustrating ‘dominant’ α-thalassemia. Hemoglobin. 1999;23(4):325–337.
  • Sharma P, Das R. Cation-exchange high performance liquid chromatography for variant hemoglobins and HbF.A2: what must hematopathologists know about methodology? World J Methodol. 2016;6(1):20–24.
  • George E, Lai MI, Teh LK, et al. Screening for intermediate and severe forms of thalassaemia in discarded red blood cells: optimization and feasibility. Med J Malaysia. 2011;66(5):429–434.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.